DEA delays decision on kratom ban after public backlash

Bowing to public pressure, the U.S. Drug Enforcement Administration (DEA) said on Thursday it had delayed a decision on whether to classify the botanical substance kratom, which is available online in the United States as a dietary supplement, as a dangerous drug with no medicinal use.